Research Article
Diabetic Distal Symmetrical Polyneuropathy: Correlation of Clinical, Laboratory, and Electrophysiologic Studies in Patients with Type 2 Diabetes Mellitus
Table 5
Demographic characteristics, neurologic examinations, and electrophysiologic studies for the symptomatic and asymptomatica patients.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abbreviations: mMNSI: modified Michigan Neuropathy Screening Instrument; DSPN: distal symmetrical polyneuropathy; DPNP: diabetic peripheral neuropathic pain; NCS: nerve conduction studies; DN4: Douleur Neuropathique; F: females; M: males; y: years; BMI: body mass index; T2DM: type II diabetes mellitus; HTN: hypertension; HbA1C: glycated haemoglobin; Vit. B12: vitamin B12; HTN: hypertension; Hom: homocysteine; T-CHOL: total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; TG: triglyceride; eGFR: estimated glomerular filtration rate. aSymptomatic DSPN was defined as complaint of symmetrical, bilateral, distal sensory and/or motor defects. Data were presented as of F/M for gender, (%) for categorical variables, and for continuous values by the symptomatic and asymptomatic patients. Data were compared using the chi-squared test for categorical variables and the two-sample -test for continuous ones. , , and indicate significant difference when comparing the symptomatic and asymptomatic patients. |